← Leaderboards
Gertraud Stadler
Columbia Univ New York Morningside
$155,200
Attributed
$155,200
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $80K · FY2012–13$100K$75K$50K$25K$0
'12
'13
Funding mix
By agency
NIH$155,200 · 1
By mechanism
R03$155,200 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia Univ New York Morningside
Same institution · by research overlap
- Alissa Davis$1,611,997
- Kevin D Costa$3,884,611
- James L. Manley$25,325,287
- Ronald Levy$18,113,005
- Mengdi Shi$34,415
Others in their field
Top investigators on “Adherence (Attribute)”
- Jeffrey P Krischer · University Of South Florida$120,978,923
- David Heimbrook · Leidos Biomedical Research, Inc.$88,683,623
- Michelle Vargas · Ppd Development Lp$83,314,632
- Constance Ann Benson · University Of California, San Diego$67,089,733
- David M Nathan · Massachusetts Institute Of Technology$62,205,053
- John M Lachin · George Washington University$50,273,725
Research focus
Adherence (Attribute)AdultAftercareAllogenicBaseBehavioralBlood TreatmentCancer PatientCell TransplantsChronic Graft Versus Host DiseaseClinical DataComplexCompliance BehaviorElectronic Drug MonitoringElectronicsEthnic Minority PopulationFeasibility StudiesFollow-UpGraft RejectionHealth Care CostsHematopoietic Stem CellsHomologous TransplantationHospital MortalityAcute
Grant awards (3)
Multi-Method Study of Cancer Patients' Medication Adherence After Allogeneic HSCT$75,200
R03 · FY2013 · CA · contact PI
Multi-Method Study of Cancer Patients' Medication Adherence After Allogeneic HSCT$40,563
R03 · FY2012 · CA · contact PI
Multi-Method Study of Cancer Patients' Medication Adherence After Allogeneic HSCT$39,437
R03 · FY2012 · CA · contact PI